Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

Eliza A Hawkes¹, Geoffrey Chong¹, Andrew Grigg¹

Affiliations

Affiliation

¹ Eliza A. Hawkes, Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital; and Eastern Health, Melbourne, Victoria, Australia; and Geoffrey Chong and Andrew Grigg, Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Melbourne, Victoria, Australia.

PMID: 28095269
DOI: 10.1200/JCO.2016.68.2047

Comment

Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

Eliza A Hawkes et al. J Clin Oncol. 2017.

. 2017 Jan 20;35(3):371-372.

doi: 10.1200/JCO.2016.68.2047. Epub 2016 Oct 28.

Authors

Eliza A Hawkes¹, Geoffrey Chong¹, Andrew Grigg¹

Affiliation

¹ Eliza A. Hawkes, Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital; and Eastern Health, Melbourne, Victoria, Australia; and Geoffrey Chong and Andrew Grigg, Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Melbourne, Victoria, Australia.

PMID: 28095269
DOI: 10.1200/JCO.2016.68.2047

No abstract available

PubMed Disclaimer

Comment in

Reply to H.J.A. Adams et al and E.A. Hawkes et al.
Press OW, Friedberg JW. Press OW, et al. J Clin Oncol. 2017 Jan 20;35(3):373. doi: 10.1200/JCO.2016.69.7979. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28095266 No abstract available.
Reply to H.J.A. Adams et al, E.A. Hawkes et al, and C.F. Hess et al.
Borchmann P, Engert A. Borchmann P, et al. J Clin Oncol. 2017 Jan 20;35(3):375-376. doi: 10.1200/JCO.2016.69.7987. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28095272 No abstract available.

Comment on

Balancing the Risk-Benefit Ratio in the Treatment of Patients With Advanced-Stage Hodgkin Lymphoma.
Borchmann P, Engert A. Borchmann P, et al. J Clin Oncol. 2016 Jun 10;34(17):1975-7. doi: 10.1200/JCO.2015.66.3823. Epub 2016 Apr 11. J Clin Oncol. 2016. PMID: 27069072 No abstract available.
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Press OW, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza LM, Bartlett NL, Evens AM, Mittra ES, LaCasce AS, Sweetenham JW, Barr PM, Fanale MA, Knopp MV, Noy A, Hsi ED, Cook JR, Lechowicz MJ, Gascoyne RD, Leonard JP, Kahl BS, Cheson BD, Fisher RI, Friedberg JW. Press OW, et al. J Clin Oncol. 2016 Jun 10;34(17):2020-7. doi: 10.1200/JCO.2015.63.1119. Epub 2016 Apr 11. J Clin Oncol. 2016. PMID: 27069074 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

Affiliation

Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

Authors

Affiliation

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical